Skip to main content
Journal of Feline Medicine and Surgery logoLink to Journal of Feline Medicine and Surgery
. 2013 Jun 27;15(7):631–637. doi: 10.1177/1098612X13489228

Toxoplasma Gondii Infection in Cats

ABCD guidelines on prevention and management

Katrin Hartmann , Diane Addie, Sándor Belák, Corine Boucraut-Baralon, Herman Egberink, Tadeusz Frymus, Tim Gruffydd-Jones, Margaret J Hosie, Albert Lloret, Hans Lutz, Fulvio Marsilio, Karin Möstl, Maria Grazia Pennisi, Alan D Radford, Etienne Thiry, Uwe Truyen, Marian C Horzinek
PMCID: PMC11148961  PMID: 23813830

Abstract

Overview:

Toxoplasma gondii infection is common in cats, but the clinical disease is rare. Up to 50% of cats, especially free-roaming ones, have antibodies indicating infection and the presence of cystic stages.

Disease signs:

Clinical signs only appear in few cats when they become immunosuppressed – in these situations cystic stages can be reactivated. Commonly affected are the central nervous system (CNS), muscles, lungs and eyes.

Human infection:

Cats can pose a risk for humans when they shed oocysts. However, this happens only once in their lifetime, usually only for 3–10 days after ingestion of tissue cysts. Thus, cats that have antibodies to T gondii no longer shed oocysts, and do not pose a risk to humans.

Agent properties

Toxoplasma gondii is an obligate intracellular coccidian parasite that can infect virtually all species of warm-blooded animals, including people. Domestic cats and other felids are the natural hosts – non-feline species serve only as intermediates.1,2

Three infectious structures can be distinguished: sporozoites in oocysts, tachyzoites (the actively multiplying stage), and bradyzoites (the slowly multiplying stage) enclosed in tissue cysts. Oocysts are excreted in faeces, whereas tachyzoites and bradyzoites are found in tissues and milk.1,2

Pathogenesis

Enteroepithelial life cycle

This cycle is found only in the feline host. Most cats are infected by ingesting intermediate hosts – typically rodents – infected with tissue cysts. Bradyzoites are released in the stomach and intestine from the tissue cysts when digestive enzymes dissolve the cyst wall. They enter epithelial cells of the small intestine and give rise to schizonts, initiate five types of predetermined asexual stages, and merozoites released from the schizonts eventually form male and female gamonts. After fertilisation, a wall is formed around the fertilised macrogamont to form an oocyst. Oocysts are round to oval, 10 x 12 μm in size, and are still unsporulated (not infectious) when passed in faeces. After exposure to air and moisture for 1–5 days they sporulate to contain two sporocysts, each with four sporozoites.1,2

graphic file with name 10.1177_1098612X13489228-img1.jpg

The cycle is usually completed within 3–10 days of ingestion of tissue cysts, which is the route of infection in up to 97% of naive cats. In the rare event that cats ingest oocysts or tachyzoites, formation of new oocysts is delayed and shedding can occur for up to 18 days (occasionally longer). However, only 20% of cats fed oocysts will shed.1,2

Extraintestinal life cycle

The extraintestinal development of T gondii is the same for all hosts, including cats, dogs, and people, irrespective of whether tissue cysts or oocysts have been ingested. After the ingestion of oocysts, sporozoites hatch in the lumen of the small intestine and enter intestinal cells, including those in the lamina propria. Sporozoites divide into two by an asexual process known as endodyogeny, thereby becoming tachyzoites. These are lunate (falciform) in shape, approximately 6 x 2 μm, and multiply in almost any cell of the body. When the cell ruptures, releasing the tachyzoites, these infect new cells. Otherwise, tachyzoites multiply intracellularly for an undetermined period, and eventually encyst. Tissue cysts vary in size from 15–60 μm and usually conform to the shape of the parasitised cell. Tissue cysts are formed mainly in the CNS, muscles and visceral organs, and probably persist for the life of the host. They can be reactivated after immunosuppression, which may then lead to clinical signs.1,2

Parasitaemia during pregnancy of the host can cause placentitis and spread of tachyzoites to the fetus. Many kittens born to queens infected with T gondii during gestation become infected transplacentally or when suckling. Clinical signs are common in these kittens, varying with the stage of gestation at the time of infection; some of these newborn kittens shed oocysts.1,2

Epidemiology

Antibody prevalence to T gondii varies geographically: in Portugal, 24% of cats had antibodies in one study; 3 in the USA, 16–40% were antibody-positive, depending on the state. 2 However, only 3/326 faecal samples from cats in California and 1/252 in Switzerland contained T gondii oocysts. 4 The annual burden in the environment is about 90–5000 oocysts per square metre. 5 The age of the cat does not play a role in the frequency of T gondii shedding, but the season does: shedding is more common between July and December in the northern hemisphere. 6

The three major modes of transmission of T gondii in all host species are congenital infection, ingestion of infected tissue, and ingestion of oocyst-contaminated food or water. 2 Less important are blood transfusions and organ transplantations.1,2 Lactogenic transmission is suspected because the organism has been detected in queen’s milk. 7

T gondii blocks the innate aversion of rats for cat urine, instead making them attracted by the feline pheromone, which can increase the likelihood of a cat capturing an infected rat. This reflects adaptive ‘behavioural manipulation’ by T gondii in optimising the chances of completing the parasite’s life cycle: it reproduces only in the feline intestine. The behavioural manipulation hypothesis postulates that a parasite will specifically manipulate host conduct essential for its transmission. However, the neural circuits for innate fear, anxiety and acquired fright all overlap, raising the possibility that T gondii can disrupt all of these non-specifically. 8 Experimental infections have shown that T gondii can change chemical messages in the CNS that affect rodent behaviour because the infection can lead to cyst formation in the CNS with production of tyrosine hydroxylase, resulting in a lack of dopamine.914

Meat contaminated with T gondii cysts has been the primary source of infection in people, and antibody prevalence in humans is relatively high. Exposure from oocyst-contaminated soil or water is common. Indeed, water-borne outbreaks of toxoplasmosis have been reported worldwide and support the theory that exposure to environmental oocysts poses a significant health risk. 15

Clinical signs

Clinical signs develop very rarely in infected cats and are caused by inflammation and tissue necrosis resulting from intracellular growth of tachyzoites. 2 Congenital infection tends to be more serious than infection of the adult cat. 2

Clinical toxoplasmosis develops during dissemination and intracellular replication of tachyzoites. It usually originates from reactivation of a latent infection rather than after a newly acquired infection. If a carrier cat is immunosuppressed, bradyzoites in tissue cysts replicate rapidly and disseminate again as tachyzoites. Clinical toxoplasmosis has been documented in some cats infected with feline immunodeficiency virus (FIV) or feline leukaemia virus (FeLV) [EBM grade III]. 16 Commonly used doses of glucocorticoids do not predispose to reactivation of T gondii cysts. 17 However, administration of ciclosporin to cats with renal transplants or dermatological disease has been associated with clinical manifestations [EBM grade IV].1820

The most commonly affected tissues are the CNS, muscles (Figure 1), lungs (Figure 2) and eyes. Hepatic and pancreatic involvement is less likely. Cats with toxoplasmosis show neurological signs (eg, seizures, ataxia), muscle hyperaesthesia, dyspnoea, uveitis, icterus, diarrhoea, fever, depression, anorexia and weight loss. 2 Transplacentally or lactogenically infected kittens develop more severe signs and frequently die of pulmonary or hepatic disease [EBM grade III]. 21 Immune complex formation 22 and deposition in tissues, as well as delayed hypersensitivity reactions, can be involved in chronic forms of toxoplasmosis. Since T gondii is not cleared from the body, either naturally or through treatment, toxoplasmosis can recur.

Figure 1.

Figure 1

Myositis in a cat caused by T gondii cysts. The cat presented in lateral recumbency, was unable to get up, and showed severe muscle hyperaesthesia. Courtesy of Katrin Hartmann, Ludwig Maximilians University, Munich, Germany

Figure 2.

Figure 2

Thoracic radiograph (laterolateral view) of a cat with pulmonary toxoplasmosis. Courtesy of Katrin Hartmann, Ludwig Maximilians University, Munich, Germany

Immunity

Immunity to T gondii in the cat is poorly understood. In the mouse and in humans, it is highly dependent on cell-mediated effector responses. 23

All infected cats develop IgG and IgA antibodies; about 80% also have IgM antibodies. IgG can take 4–6 weeks to appear, and maximal antibody titres are achieved within 2–3 weeks of first appearance. 2

graphic file with name 10.1177_1098612X13489228-img2.jpg

Diagnosis

Oocyst shedding is diagnosed by microscopy of faecal samples. Diagnosis of the disease is only confirmed when the organism is found in body fluids or tissue. If suitable samples cannot be taken, a tentative diagnosis is sometimes based on rising IgM titres, exclusion of other causes for the clinical signs, and a favourable clinical response to anti-T gondii drugs [EBM grade II].1,2

Detection of oocysts in faeces

T gondii oocysts are 10 μm in size and best demonstrated by centrifugation using Sheather’s sugar solution (saccharose solution with a specific gravity of 1.27 g/ml) during the shedding period. T gondii oocysts are morphologically indistinguishable from those of Hammondia hammondi, Besnoitia oryctofelisi and Besnoitia darlingi. 2 A cesium chloride method for easy purification of T gondii oocysts from faeces of infected cats has been described. 15

Detection of tachyzoites

Ante-mortem diagnosis of clinical toxoplasmosis ideally is based on the detection of the organism by cytology or polymerase chain reaction (PCR) [EBM grade III]. Tachyzoites can be detected in various tissues and body fluids during acute illness (Figure 3). They are rarely found in blood, but occasionally in cerebrospinal fluid (CSF) or aqueous humour, fine-needle aspirates of organs (eg, lymph nodes), and transtracheal or bronchoalveolar lavage fluid. Detection of tachyzoites results in a definitive diagnosis. Alternatively, a PCR can be performed using CSF, aqueous humour or bronchoalveolar lavage fluid.

Figure 3.

Figure 3

Cytology of a fine-needle aspirate from a cat with pulmonary toxoplasmosis and lung consolidation, showing numerous intracellular and extracellular T gondii tachyzoites and cysts (arrows). Courtesy of George Reppas, Vetnostics, Australia

Detection of antibodies

Using the immunofluorescence assay (IFA), antibodies of the IgM, IgG and IgA isotypes can be detected. For assessing human health risks, antibody test results from healthy cats are useful. An antibody-negative cat can be shedding oocysts (early during infection, before antibodies have had time to develop) and will likely shed oocysts if exposed for the first time. An antibody-positive cat does not shed oocysts: antibodies need 2–3 weeks to develop, by which time cats usually no longer shed; and a cat sheds only once in its lifetime. It is also unlikely to shed oocysts if re-exposed or immunosuppressed [EBM grade II]. 1

Antibodies are commonly found in both healthy and sick cats. Thus, their presence does not prove clinical toxoplasmosis. Antibodies of the IgM class are also commonly detected in healthy cats and do not correlate with clinical signs.

Treatment

Clindamycin is the treatment of choice 24 and should be administered at 10–12 mg/kg orally q12h for 4 weeks (Table 1) [EBM grade III]. Cats with systemic disease and uveitis should be treated with clindamycin in combination with topical, oral or parenteral glucocorticoids, to avoid secondary glaucoma and lens luxation [EBM grade III]. 25 Prednisolone acetate (1% solution) applied topically to the eye three to four times daily is generally sufficient.

Table 1.

Treatment of toxoplasmosis

Drug Comment ABCD recommendation EBM grade
Antiparasitic therapy
Clindamycin 10–12 mg/kg PO q12h for 4 weeks (treatment of choice) III
Symptomatic therapy
Prednisolone acetate (1%) For cats with Toxoplasma-induced uveitis (to avoid secondary glaucoma and lens luxation) Use in addition to systemic antibiotic treatment
Apply topically to the eye q6–8h
IV

Clinical signs not involving the eyes or the CNS usually begin to resolve within the first 2–3 days of clindamycin administration. CNS and ocular toxoplasmosis tend to respond more slowly. In cases of pulmonary toxoplasmosis, radiographic abnormalities might not resolve for several weeks. The prognosis is usually poor in pulmonary or hepatic disease, particularly in immunocompromised animals. 26

Prevention of infection

Preventing toxoplasmosis in cats involves measures intended to reduce the incidence of infections and the shedding of oocysts into the environment. Cats should preferably be fed commercially available, processed food. Prevalence of feline T gondii infection is higher in countries where raw meat is fed. Freezing or irradiation can kill tissue cysts without affecting meat quality. Pets should be prevented from hunting and eating intermediate hosts (rodents) or mechanical vectors, such as cockroaches and earthworms. If meat is fed, it should be thoroughly cooked, even if frozen. Cats should be prevented from entering buildings where food-producing animals are housed or where feed storage areas are located. 1

graphic file with name 10.1177_1098612X13489228-img3.jpg

Footnotes

Funding: The authors received no specific grant from any funding agency in the public, commercial or not-for-profit sectors for the preparation of this article. The ABCD is supported by Merial, but is a scientifically independent body.

The authors do not have any potential conflicts of interest to declare.

Key Points

  • T gondii infection is common in cats. The clinical picture toxoplasmosis, however, is rare.

  • Up to 50% of cats have antibodies, which show they are infected and harbour T gondii cysts.

  • Clinical signs usually occur when cats become immunosuppressed, due to the reactivation of cystic stages.

  • Commonly affected sites are the CNS, muscles, lungs and eyes.

  • Cats shedding oocysts can pose a risk to humans. However, they shed only once in their lifetime, and usually for only 3–10 days after ingestion of tissue cysts.

  • Cats with T gondii antibodies no longer shed oocysts; they neither are nor will become a zoonotic risk.

  • A definitive diagnosis of toxoplasmosis relies on the detection of the organism in body fluids or tissues.

  • The treatment of choice for cats with the disease toxoplasmosis is clindamycin.

References

  • 1. Dubey JP. Toxoplasma update. Proceedings of the WSAVA Congress; 2005, Mexico City, Mexico. [Google Scholar]
  • 2. Dubey JP, Lappin MR. Toxoplasmosis and neosporosis. In: Greene CE. (ed). Infectious disease of the dog and cat. Philadelphia: WB Saunders, 2006, pp 754–775. [Google Scholar]
  • 3. Duarte A, Castro I, Pereira da Fonseca IM, Almeida V, Madeira de Carvalho LM, Meireles J, et al. Survey of infectious and parasitic diseases in stray cats at the Lisbon Metropolitan Area, Portugal. J Feline Med Surg 2010; 12: 441–446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Berger-Schoch AE, Herrmann DC, Schares G, Muller N, Bernet D, Gottstein B, et al. Prevalence and genotypes of Toxoplasma gondii in feline faeces (oocysts) and meat from sheep, cattle and pigs in Switzerland. Vet Parasitol 2011; 177: 290–297. [DOI] [PubMed] [Google Scholar]
  • 5. Dabritz HA, Miller MA, Atwill ER, Gardner IA, Leutenegger CM, Melli AC, et al. Detection of Toxoplasma gondii-like oocysts in cat feces and estimates of the environmental oocyst burden. J Am Vet Med Assoc 2007; 231: 1676–1684. [DOI] [PubMed] [Google Scholar]
  • 6. Herrmann DC, Pantchev N, Vrhovec MG, Barutzki D, Wilking H, Frohlich A, et al. Atypical Toxoplasma gondii genotypes identified in oocysts shed by cats in Germany. Int J Parasitol 2010; 40: 285–292. [DOI] [PubMed] [Google Scholar]
  • 7. Powell CC, Brewer M, Lappin MR. Detection of Toxoplasma gondii in the milk of experimentally infected lactating cats. Vet Parasitol 2001; 102: 29–33. [DOI] [PubMed] [Google Scholar]
  • 8. Vyas A, Kim SK, Giacomini N, Boothroyd JC, Sapolsky RM. Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc Natl Acad Sci U S A 2007; 104: 6442–6447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Flegr J, Havlicek J. Changes in the personality profile of young women with latent toxoplasmosis. Folia Parasitol 1999; 46: 22–28. [PubMed] [Google Scholar]
  • 10. Hrda S, Votypka J, Kodym P, Flegr J. Transient nature of Toxoplasma gondii-induced behavioral changes in mice. J Parasitol 2000; 86: 657–663. [DOI] [PubMed] [Google Scholar]
  • 11. Havlicek J, Gasova ZG, Smith AP, Zvara K, Flegr J. Decrease of psychomotor performance in subjects with latent ‘asymptomatic’ toxoplasmosis. Parasitology 2001; 122: 515–520. [DOI] [PubMed] [Google Scholar]
  • 12. Webster JP. Rats, cats, people and parasites: the impact of latent toxoplasmosis on behaviour. Microbes Infect 2001; 3: 1037–1045. [DOI] [PubMed] [Google Scholar]
  • 13. Flegr J, Havlicek J, Kodym P, Maly M, Smahel Z. Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect Dis 2002; 2: 11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Flegr J, Preiss M, Klose J, Havlicek J, Vitakova M, Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis? Biol Psychol 2003; 63: 253–268. [DOI] [PubMed] [Google Scholar]
  • 15. Staggs SE, See MJ, Dubey JP, Villegas EN. Obtaining highly purified Toxoplasma gondii oocysts by a discontinuous cesium chloride gradient. J Vis Exp 2009; 33: pii, 1420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Davidson MG, Rottman JB, English RV, Lappin MR, Tompkins MB. Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis. Am J Pathol 1993; 143: 1486–1497. [PMC free article] [PubMed] [Google Scholar]
  • 17. Lappin MR, Dawe DL, Windl PA, Greene CE, Prestwood AK. The effect of glucocorticoid administration on oocyst shedding, serology, and cell mediated immune responses of cats with recent or chronic toxoplasmosis. J Am Anim Hosp Assoc 1992; 27: 625–632. [Google Scholar]
  • 18. Beatty J, Barrs V. Acute toxoplasmosis in two cats on cyclosporin therapy. Aust Vet J 2003; 81: 339. [DOI] [PubMed] [Google Scholar]
  • 19. Last RD, Suzuki Y, Manning T, Lindsay D, Galipeau L, Whitbread TJ. A case of fatal systemic toxoplasmosis in a cat being treated with cyclosporin A for feline atopy. Vet Dermatol 2004; 15: 194–198. [DOI] [PubMed] [Google Scholar]
  • 20. Barrs VR, Martin P, Beatty JA. Antemortem diagnosis and treatment of toxoplasmosis in two cats on cyclosporin therapy. Aust Vet J 2006; 84: 30–35. [DOI] [PubMed] [Google Scholar]
  • 21. Dubey JP, Lappin MR, Thulliez P. Diagnosis of induced toxoplasmosis in neonatal cats. J Am Vet Med Assoc 1995; 207: 179–185. [PubMed] [Google Scholar]
  • 22. Lappin MR, Cayatte S, Powell CC, Gigliotti A, Cooper C, Roberts SM. Detection of Toxoplasma gondii antigen-containing immune complexes in the serum of cats. Am J Vet Res 1993; 54: 415–419. [PubMed] [Google Scholar]
  • 23. Sanchez Y, Rosado Jde D, Vega L, Elizondo G, Estrada-Muniz E, Saavedra R, et al. The unexpected role for the aryl hydrocarbon receptor on susceptibility to experimental toxoplasmosis. J Biomed Biotechnol Epub 11 January 2010. DOI: 10.1155/2010/505694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Davidson MG. Toxoplasmosis. Vet Clin North Am Small Anim Pract 2000; 30: 1051–1062. [DOI] [PubMed] [Google Scholar]
  • 25. Lappin MR, Greene CE, Winston S, Toll SL, Epstein ME. Clinical feline toxoplasmosis. Serologic diagnosis and therapeutic management of 15 cases. J Vet Intern Med 1998; 3: 139–143. [DOI] [PubMed] [Google Scholar]
  • 26. Dubey JP, Lindsay DS, Lappin MR. Toxoplasmosis and other intestinal coccidial infections in cats and dogs. Vet Clin North Am Small Anim Pract 2009; 39: 1009–1034, v. [DOI] [PubMed] [Google Scholar]
  • 27. Jones JL, Krueger A, Schulkin J, Schantz PM. Toxoplasmosis prevention and testing in pregnancy, survey of obstetrician-gynaecologists. Zoonoses Public Health 2010; 57: 27–33. [DOI] [PubMed] [Google Scholar]
  • 28. Leroy V, Hadjichristodoulou C. Systematic review of risk factors for Toxoplasma gondii infection in pregnant women. Bordeaux, France, The Eurotoxic Group, 2005. [Google Scholar]
  • 29. Lunden A, Uggla A. Infectivity of Toxoplasma gondii in mutton following curing, smoking, freezing or microwave cooking. Int J Food Microbiol 1992; 15: 357–363. [DOI] [PubMed] [Google Scholar]
  • 30. Dubey JP. Long-term persistence of Toxoplasma gondii in tissues of pigs inoculated with T gondii oocysts and effect of freezing on viability of tissue cysts in pork. Am J Vet Res 1988; 49: 910–913. [PubMed] [Google Scholar]
  • 31. Dubey JP. Toxoplasma gondii oocyst survival under defined temperatures. J Parasitol 1998; 84: 862–865. [PubMed] [Google Scholar]
  • 32. Dubey JP, Kotula AW, Sharar A, Andrews CD, Lindsay DS. Effect of high temperature on infectivity of Toxoplasma gondii tissue cysts in pork. J Parasitol 1990; 76: 201–204. [PubMed] [Google Scholar]
  • 33. Elmore SA, Jones JL, Conrad PA, Patton S, Lindsay DS, Dubey JP. Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends Parasitol 2010; 26: 190–196. [DOI] [PubMed] [Google Scholar]
  • 34. Hill SL, Cheney JM, Taton-Allen GF, Reif JS, Bruns C, Lappin MR. Prevalence of enteric zoonotic organisms in cats. J Am Vet Med Assoc 2000; 216: 687–692. [DOI] [PubMed] [Google Scholar]
  • 35. Flegr J, Hrda S, Tachezy J. The role of psychological factors in questionnaire-based studies on routes of human toxoplasmosis transmission. Cent Eur J Public Health 1998; 6: 45–50. [PubMed] [Google Scholar]
  • 36. Behymer RD, Harlow DR, Behymer DE, Franti CE. Serologic diagnosis of toxoplasmosis and prevalence of Toxoplasma gondii antibodies in selected feline, canine, and human populations. J Am Vet Med Assoc 1973; 162: 959–963. [PubMed] [Google Scholar]
  • 37. Sengbusch HG, Sengbusch LA. Toxoplasma antibody prevalence in veterinary personnel and a selected population not exposed to cats. Am J Epidemiol 1976; 103: 595–597. [DOI] [PubMed] [Google Scholar]
  • 38. DiGiacomo RF, Harris NV, Huber NL, Cooney MK. Animal exposures and antibodies to Toxoplasma gondii in a university population. Am J Epidemiol 1990; 131: 729–733. [DOI] [PubMed] [Google Scholar]
  • 39. Dubey JP. Duration of immunity to shedding of Toxoplasma gondii oocysts by cats. J Parasitol 1995; 81: 410–415. [PubMed] [Google Scholar]
  • 40. Lindsay DS, Dubey JP, Butler JM, Blagburn BL. Mechanical transmission of Toxoplasma gondii oocysts by dogs. Vet Parasitol 1997; 73: 27–33. [DOI] [PubMed] [Google Scholar]
  • 41. Wallace MR, Rossetti RJ, Olson PE. Cats and toxoplasmosis risk in HIV-infected adults. JAMA 1993; 269: 76–77. [PubMed] [Google Scholar]
  • 42. Lappin MR. Cat ownership by immunosuppressed people. In: August JR. (ed). Consultations in feline medicine. 4th ed. Philadelphia: WB Saunders, 2001, pp 18–27. [Google Scholar]
  • 43. Lappin MR, George JW, Pedersen NC, Barlough JE, Murphy CJ, Morse LS. Primary and secondary Toxoplasma gondii infection in normal and feline immunodeficiency virus-infected cats. J Parasitol 1996; 82: 733–742. [PubMed] [Google Scholar]

Articles from Journal of Feline Medicine and Surgery are provided here courtesy of SAGE Publications

RESOURCES